Award recordCONTRACT

EMED MEDICAL COMPANY, LLC

PIID VA25515P0217· VHA· NATIONAL CMOP OFFICE (NCO)· 6505 · DRUGS AND BIOLOGICALS· FY2015· $198,105 net obligations· UEI Q1C1HTLU9ZY3· MO

Description

MOD 1 - PRICE REDUCTION CYCLOPHOSPHAMIDE 50MG NDC: 00054-0383-25 METFORMIN HCL (FORTAMET) 1000MG SA TAB NDC: 59630-0575-60

Base award description: CYCLOPHOSPHAMIDE 50MG NDC: 00054-0383-25 METFORMIN HCL (FORTAMET) 1000MG SA TAB NDC: 59630-0575-60

First action · last action
2014-10-23 · 2014-10-23
Transactions
2
First transaction's obligation
$202,758
Base + all options value (sum of deltas)
$198,105
Extent competed
FULL AND OPEN COMPETITION AFTER EXCLUSION OF SOURCES
Other than full & open authority
URGENCY
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$202,758$0Base award · 2014-10-23 · this action $202,758 · running total $202,758Modification P00001 · 2014-10-23 · this action -$4,653 · running total $198,105
  • Base2014-10-23+$202,758= $202,758
  • Mod P000012014-10-23-$4,653= $198,105
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2014-10-23+$202,758$202,758CYCLOPHOSPHAMIDE 50MG NDC: 00054-0383-25 METFORMIN HCL (FORTAMET) 1000MG SA TAB NDC: 59630-0575-60
Mod P00001· CHANGE ORDER2014-10-23−$4,653$198,105MOD 1 - PRICE REDUCTION CYCLOPHOSPHAMIDE 50MG NDC: 00054-0383-25 METFORMIN HCL (FORTAMET) 1000MG SA TAB NDC:…

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI Q1C1HTLU9ZY3)

AwardOffice · PSC / listingNet obligationsFY
36C77021P0260NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$17,856FY2021
36C77021P0222NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$6,420FY2021
36C77021P0079NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$325,845FY2021
36C77020P0925NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$30,580FY2020
36C77020P0838NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$42,255FY2020
36C77020P0664NATIONAL CMOP OFFICE (36C770) · 6505 · DRUGS AND BIOLOGICALS$29,559FY2020

Other recipients under 6505 from NATIONAL CMOP OFFICE (NCO) (most recent first)

AwardRecipientOfficeNet obligationsFY
VA77016P0844ROCHE DIABETES CARE INCNATIONAL CMOP OFFICE (NCO)$494,384FY2016
VA77016P0843D & H WHOLESALE MEDICAL, INC.NATIONAL CMOP OFFICE (NCO)$30,360FY2016
VA77016E0865SOUND PACKAGING LLCNATIONAL CMOP OFFICE (NCO)$11,462FY2016
VA77016E08623M COMPANYNATIONAL CMOP OFFICE (NCO)$9,177FY2016
VA77016P0827UNITED DRUG SUPPLY INCNATIONAL CMOP OFFICE (NCO)$13,061FY2016

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25515P0217_3600_-NONE-_-NONE- · retrieved 2026-09-26.